Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Morgan L. Marshall"'
Autor:
Morgan L. Marshall, Kylie M. Wagstaff
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Despite major advances, cancer remains one of the largest burdens of disease worldwide. One reason behind this is that killing tumor cells without affecting healthy surrounding tissue remains a largely elusive prospect, despite the widespread availab
Externí odkaz:
https://doaj.org/article/deafd2e6492645ac887c1ba558d5a159
Autor:
James J. Dowling, Romain Joubert, Sean E. Low, Ashley N. Durban, Nadia Messaddeq, Xingli Li, Ashley N. Dulin-Smith, Andrew D. Snyder, Morgan L. Marshall, Jordan T. Marshall, Alan H. Beggs, Anna Buj-Bello, Christopher R. Pierson
Publikováno v:
Disease Models & Mechanisms, Vol 5, Iss 6, Pp 852-859 (2012)
SUMMARY Myotubular myopathy (MTM) is a severe congenital muscle disease characterized by profound weakness, early respiratory failure and premature lethality. MTM is defined by muscle biopsy findings that include centralized nuclei and disorganizatio
Externí odkaz:
https://doaj.org/article/261ac33dd5b44ad292b315296e2ef427
Publikováno v:
Cell & Bioscience, Vol 14, Iss 1, Pp 1-22 (2024)
Abstract Background The glycolytic enzyme alpha-enolase is a known biomarker of many cancers and involved in tumorigenic functions unrelated to its key role in glycolysis. Here, we show that expression of alpha-enolase correlates with subcellular loc
Externí odkaz:
https://doaj.org/article/ebc6ef5325644d92b45ceca6d5fe45d8
Autor:
Kylie M. Wagstaff, Morgan L Marshall
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology, Vol 11 (2020)
Despite major advances, cancer remains one of the largest burdens of disease worldwide. One reason behind this is that killing tumor cells without affecting healthy surrounding tissue remains a largely elusive prospect, despite the widespread availab
Autor:
Andrew D. Snyder, Ashley N. Dulin-Smith, R. Joubert, Xingli Li, Alan H. Beggs, Christopher R. Pierson, Morgan L. Marshall, Sean E. Low, Anna Buj-Bello, Ashley N. Durban, Jordan T. Marshall, James J. Dowling, Nadia Messaddeq
Publikováno v:
Disease Models & Mechanisms, Vol 5, Iss 6, Pp 852-859 (2012)
Disease Models & Mechanisms
Disease Models & Mechanisms, Cambridge Company of Biologists, 2012, 5 (6), pp.852-859. ⟨10.1242/DMM.009746⟩
Disease Models & Mechanisms, Cambridge Company of Biologists, 2012, 5 (6), pp.852-9. ⟨10.1242/dmm.009746⟩
Disease Models & Mechanisms, 2012, 5 (6), pp.852-9. ⟨10.1242/dmm.009746⟩
Disease Models & Mechanisms, 2012, 5 (6), pp.852-859. ⟨10.1242/DMM.009746⟩
Disease Models & Mechanisms
Disease Models & Mechanisms, Cambridge Company of Biologists, 2012, 5 (6), pp.852-859. ⟨10.1242/DMM.009746⟩
Disease Models & Mechanisms, Cambridge Company of Biologists, 2012, 5 (6), pp.852-9. ⟨10.1242/dmm.009746⟩
Disease Models & Mechanisms, 2012, 5 (6), pp.852-9. ⟨10.1242/dmm.009746⟩
Disease Models & Mechanisms, 2012, 5 (6), pp.852-859. ⟨10.1242/DMM.009746⟩
Summary Myotubular myopathy (MTM) is a severe congenital muscle disease characterized by profound weakness, early respiratory failure and premature lethality. MTM is defined by muscle biopsy findings that include centralized nuclei and disorganizatio
Autor:
Ashley N. Dulin-Smith, Jordan T. Marshall, Morgan L. Marshall, Michael W. Lawlor, Andrew D. Snyder, Jordan T. Gladman, Nada Naiyer, Anna Buj-Bello, Dawn S. Chandler, James J. Dowling, Alan H. Beggs, Christopher R. Pierson, Ashley N. Durban
Publikováno v:
Hum Mol Genet
Hum Mol Genet, 2012, 21 (4), pp.811-25. ⟨10.1093/hmg/ddr512⟩
Hum Mol Genet, 2012, 21 (4), pp.811-25. ⟨10.1093/hmg/ddr512⟩
International audience; X-linked myotubular myopathy (MTM) is a severe neuromuscular disease of infancy caused by mutations of MTM1, which encodes the phosphoinositide lipid phosphatase, myotubularin. The Mtm1 knockout (KO) mouse has a severe phenoty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bc56e18387f4bf3b1c587213a0022ae
https://hal.archives-ouvertes.fr/hal-02881147
https://hal.archives-ouvertes.fr/hal-02881147